These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1810452

  • 1. Mechanism of BCG induced regression of line 10 hepatocarcinoma in the guinea pig.
    Steerenberg PA, De Jong WH, Ruitenberg EJ.
    In Vivo; 1991; 5(6):655-61. PubMed ID: 1810452
    [Abstract] [Full Text] [Related]

  • 2. Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression.
    Steerenberg PA, De Jong WH, Geerse E, De Graaf A, Scheper RJ, Den Otter W, Ruitenberg EJ.
    Cancer Immunol Immunother; 1991; 33(3):189-97. PubMed ID: 1828389
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [Abstract] [Full Text] [Related]

  • 4. Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin.
    Steerenberg PA, De Jong WH, Geerse E, Aleva BJ, Besselink CM, Van Rens BT, Rutten VP, Poels LG, Scheper RJ, Den Otter W.
    Cancer Immunol Immunother; 1990 Oct; 32(2):95-104. PubMed ID: 1963114
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH, van de Plas MM, Steerenberg PA, Kruizinga W, Ruitenberg EJ.
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activity.
    Balemans LT, Mattijssen V, Steerenberg PA, Van Driel BE, De Mulder PH, Den Otter W.
    Cancer Immunol Immunother; 1993 Jul; 37(1):7-14. PubMed ID: 8513455
    [Abstract] [Full Text] [Related]

  • 10. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria.
    Yarkoni E, Rapp HJ.
    Cancer Res; 1979 Feb; 39(2 Pt 1):535-7. PubMed ID: 761228
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P, Mathews HL.
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
    McMurray DN, Allen SS, Jeevan A, Lasco T, Cho H, Skwor T, Yamamoto T, McFarland C, Yoshimura T.
    Tuberculosis (Edinb); 2005 Sep; 85(5-6):295-301. PubMed ID: 16253558
    [Abstract] [Full Text] [Related]

  • 20. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM, Ninalga C, Essand M, Loskog A, Tötterman TH.
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.